| Chemical Name: 2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-.alpha.-L-lyxo-hexopyranosyl]-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]-oxy]-1-naphthacenecarboxalic acid methyl ester |
Synonyms
- Aclarubicin
- Jaclacin
- Spartanamicin B
- Aclacinomycin A
- NSC208734
|
AIDS# 000124 |
|
Links to ChemID Plus by CAS#
57576-44-0
|
|
|
Links to PubChem by AIDS#
000124
|
|
ISOLATED FROM STREPTOMYCES GALILAEUS
|
| C42 H53 N O15
|
MW: 811.87
|
Links to PubMed by CAS#
|
| H-bond donors:
4 |
H-bond acceptors:
16
|
PHIA (Flexible Bonds):
12.23 |
Calc. LogP (MDL QSAR):
1.72
|
| Company:
BRISTOL-MYERS SQUIBB |
Calc. LogP (KowWin): 2.53 |
Lines of Data: 1
|
Anti-HIV Enzyme data: 0
|
Lines of Data: 11
|
TB Min MIC
|
TB Min IC50
|
Links to NIST by AIDS#
|
Number of References: 1
|
Number of References: 0
|
Number of References: 3
|
Lipinski: 2
(Score, out of 4)
|
| Classes: NATURAL PRODUCTS; ANTIBIOTICS; ANTINEOPLASTICS; ANTHRACYCLINES; MYCINS |